nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Venous thrombosis—Carboplatin—brain cancer	0.0352	0.0387	CcSEcCtD
Metolazone—Skin necrosis—Hydroxyurea—brain cancer	0.0234	0.0257	CcSEcCtD
Metolazone—Throat sore—Lomustine—brain cancer	0.0231	0.0253	CcSEcCtD
Metolazone—Oropharyngeal discomfort—Lomustine—brain cancer	0.0229	0.0251	CcSEcCtD
Metolazone—Skin necrosis—Carmustine—brain cancer	0.0189	0.0208	CcSEcCtD
Metolazone—Oropharyngeal pain—Lomustine—brain cancer	0.0183	0.0201	CcSEcCtD
Metolazone—Skin necrosis—Etoposide—brain cancer	0.0146	0.0161	CcSEcCtD
Metolazone—Hypomagnesaemia—Hydroxyurea—brain cancer	0.0129	0.0141	CcSEcCtD
Metolazone—Petechiae—Procarbazine—brain cancer	0.0128	0.0141	CcSEcCtD
Metolazone—Lethargy—Lomustine—brain cancer	0.0123	0.0135	CcSEcCtD
Metolazone—Nocturia—Procarbazine—brain cancer	0.0114	0.0125	CcSEcCtD
Metolazone—Neuropathy—Procarbazine—brain cancer	0.00992	0.0109	CcSEcCtD
Metolazone—Hyperuricaemia—Hydroxyurea—brain cancer	0.00881	0.00967	CcSEcCtD
Metolazone—Photosensitivity—Procarbazine—brain cancer	0.00873	0.00959	CcSEcCtD
Metolazone—Vascular purpura—Procarbazine—brain cancer	0.00857	0.00941	CcSEcCtD
Metolazone—Blood uric acid increased—Hydroxyurea—brain cancer	0.00832	0.00914	CcSEcCtD
Metolazone—Purpura—Procarbazine—brain cancer	0.00795	0.00873	CcSEcCtD
Metolazone—Lethargy—Procarbazine—brain cancer	0.00782	0.00859	CcSEcCtD
Metolazone—Skin exfoliation—Hydroxyurea—brain cancer	0.0078	0.00857	CcSEcCtD
Metolazone—Petechiae—Temozolomide—brain cancer	0.00776	0.00852	CcSEcCtD
Metolazone—Blood urea increased—Hydroxyurea—brain cancer	0.00772	0.00847	CcSEcCtD
Metolazone—CA4—ganglion—brain cancer	0.00732	0.0822	CbGeAlD
Metolazone—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.0069	0.00758	CcSEcCtD
Metolazone—CA5A—endocrine gland—brain cancer	0.00666	0.0747	CbGeAlD
Metolazone—Leukopenia—Lomustine—brain cancer	0.00651	0.00715	CcSEcCtD
Metolazone—Pancreatitis—Procarbazine—brain cancer	0.0065	0.00713	CcSEcCtD
Metolazone—Skin exfoliation—Carmustine—brain cancer	0.00631	0.00693	CcSEcCtD
Metolazone—Neuropathy—Carmustine—brain cancer	0.0062	0.00681	CcSEcCtD
Metolazone—Skin exfoliation—Temozolomide—brain cancer	0.0061	0.00669	CcSEcCtD
Metolazone—Photosensitivity reaction—Procarbazine—brain cancer	0.00605	0.00664	CcSEcCtD
Metolazone—Neuropathy—Temozolomide—brain cancer	0.00599	0.00658	CcSEcCtD
Metolazone—Drowsiness—Procarbazine—brain cancer	0.00591	0.00649	CcSEcCtD
Metolazone—Thrombocytopenia—Lomustine—brain cancer	0.00581	0.00638	CcSEcCtD
Metolazone—Pain—Carboplatin—brain cancer	0.0058	0.00637	CcSEcCtD
Metolazone—Neuropathy peripheral—Procarbazine—brain cancer	0.00579	0.00636	CcSEcCtD
Metolazone—Anorexia—Lomustine—brain cancer	0.00566	0.00621	CcSEcCtD
Metolazone—Epistaxis—Procarbazine—brain cancer	0.00557	0.00612	CcSEcCtD
Metolazone—CA4—hindbrain—brain cancer	0.00555	0.0623	CbGeAlD
Metolazone—Hyperuricaemia—Etoposide—brain cancer	0.00551	0.00605	CcSEcCtD
Metolazone—Swelling—Carmustine—brain cancer	0.00544	0.00597	CcSEcCtD
Metolazone—Blood uric acid increased—Etoposide—brain cancer	0.0052	0.00571	CcSEcCtD
Metolazone—Vascular purpura—Temozolomide—brain cancer	0.00518	0.00569	CcSEcCtD
Metolazone—Decreased appetite—Lomustine—brain cancer	0.00516	0.00566	CcSEcCtD
Metolazone—CA7—midbrain—brain cancer	0.00504	0.0566	CbGeAlD
Metolazone—Pancreatitis—Hydroxyurea—brain cancer	0.00503	0.00552	CcSEcCtD
Metolazone—Skin exfoliation—Etoposide—brain cancer	0.00488	0.00536	CcSEcCtD
Metolazone—Hyponatraemia—Carmustine—brain cancer	0.00482	0.00529	CcSEcCtD
Metolazone—Purpura—Temozolomide—brain cancer	0.00481	0.00528	CcSEcCtD
Metolazone—Neuropathy—Etoposide—brain cancer	0.0048	0.00527	CcSEcCtD
Metolazone—Chills—Procarbazine—brain cancer	0.00476	0.00522	CcSEcCtD
Metolazone—Drowsiness—Hydroxyurea—brain cancer	0.00457	0.00502	CcSEcCtD
Metolazone—CA12—telencephalon—brain cancer	0.00456	0.0512	CbGeAlD
Metolazone—Tension—Procarbazine—brain cancer	0.00453	0.00497	CcSEcCtD
Metolazone—Nervousness—Procarbazine—brain cancer	0.00448	0.00492	CcSEcCtD
Metolazone—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00448	0.00492	CcSEcCtD
Metolazone—Hypokalaemia—Carmustine—brain cancer	0.00436	0.00479	CcSEcCtD
Metolazone—Anaemia—Procarbazine—brain cancer	0.00427	0.00468	CcSEcCtD
Metolazone—Dry skin—Temozolomide—brain cancer	0.00425	0.00466	CcSEcCtD
Metolazone—Hypokalaemia—Temozolomide—brain cancer	0.00422	0.00463	CcSEcCtD
Metolazone—Swelling—Etoposide—brain cancer	0.0042	0.00462	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00417	0.00458	CcSEcCtD
Metolazone—Syncope—Procarbazine—brain cancer	0.00414	0.00455	CcSEcCtD
Metolazone—Leukopenia—Procarbazine—brain cancer	0.00413	0.00454	CcSEcCtD
Metolazone—Loss of consciousness—Procarbazine—brain cancer	0.00406	0.00445	CcSEcCtD
Metolazone—Abdominal distension—Temozolomide—brain cancer	0.00403	0.00443	CcSEcCtD
Metolazone—Cough—Procarbazine—brain cancer	0.00403	0.00442	CcSEcCtD
Metolazone—Hypertension—Procarbazine—brain cancer	0.00399	0.00438	CcSEcCtD
Metolazone—Arthralgia—Procarbazine—brain cancer	0.00393	0.00432	CcSEcCtD
Metolazone—Anxiety—Procarbazine—brain cancer	0.00392	0.0043	CcSEcCtD
Metolazone—CA7—cerebellum—brain cancer	0.0039	0.0438	CbGeAlD
Metolazone—CA9—endocrine gland—brain cancer	0.00389	0.0436	CbGeAlD
Metolazone—Dry mouth—Procarbazine—brain cancer	0.00384	0.00422	CcSEcCtD
Metolazone—Vomiting—Lomustine—brain cancer	0.00377	0.00414	CcSEcCtD
Metolazone—Hyperglycaemia—Carmustine—brain cancer	0.00374	0.00411	CcSEcCtD
Metolazone—Shock—Procarbazine—brain cancer	0.00371	0.00407	CcSEcCtD
Metolazone—Erectile dysfunction—Temozolomide—brain cancer	0.00369	0.00405	CcSEcCtD
Metolazone—Thrombocytopenia—Procarbazine—brain cancer	0.00369	0.00405	CcSEcCtD
Metolazone—Chills—Hydroxyurea—brain cancer	0.00368	0.00404	CcSEcCtD
Metolazone—Photosensitivity reaction—Temozolomide—brain cancer	0.00366	0.00401	CcSEcCtD
Metolazone—Neuropathy peripheral—Carmustine—brain cancer	0.00362	0.00398	CcSEcCtD
Metolazone—Hyperglycaemia—Temozolomide—brain cancer	0.00361	0.00397	CcSEcCtD
Metolazone—Anorexia—Procarbazine—brain cancer	0.00359	0.00394	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00354	0.00389	CcSEcCtD
Metolazone—Nausea—Lomustine—brain cancer	0.00353	0.00387	CcSEcCtD
Metolazone—Neuropathy peripheral—Temozolomide—brain cancer	0.0035	0.00384	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00343	0.00377	CcSEcCtD
Metolazone—CA9—cerebellum—brain cancer	0.00343	0.0384	CbGeAlD
Metolazone—CA5B—gonad—brain cancer	0.00342	0.0383	CbGeAlD
Metolazone—Insomnia—Procarbazine—brain cancer	0.00341	0.00374	CcSEcCtD
Metolazone—Paraesthesia—Procarbazine—brain cancer	0.00338	0.00371	CcSEcCtD
Metolazone—Somnolence—Procarbazine—brain cancer	0.00335	0.00368	CcSEcCtD
Metolazone—Cramp muscle—Etoposide—brain cancer	0.00334	0.00367	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00334	0.00367	CcSEcCtD
Metolazone—Ill-defined disorder—Hydroxyurea—brain cancer	0.00332	0.00364	CcSEcCtD
Metolazone—Anaemia—Hydroxyurea—brain cancer	0.0033	0.00363	CcSEcCtD
Metolazone—Decreased appetite—Procarbazine—brain cancer	0.00328	0.0036	CcSEcCtD
Metolazone—Fatigue—Procarbazine—brain cancer	0.00325	0.00357	CcSEcCtD
Metolazone—Malaise—Hydroxyurea—brain cancer	0.00322	0.00354	CcSEcCtD
Metolazone—Constipation—Procarbazine—brain cancer	0.00322	0.00354	CcSEcCtD
Metolazone—Pain—Procarbazine—brain cancer	0.00322	0.00354	CcSEcCtD
Metolazone—Hepatitis—Temozolomide—brain cancer	0.00321	0.00352	CcSEcCtD
Metolazone—Leukopenia—Hydroxyurea—brain cancer	0.0032	0.00351	CcSEcCtD
Metolazone—CA4—brainstem—brain cancer	0.00318	0.0357	CbGeAlD
Metolazone—CA7—brain—brain cancer	0.00317	0.0356	CbGeAlD
Metolazone—Feeling abnormal—Procarbazine—brain cancer	0.0031	0.00341	CcSEcCtD
Metolazone—Gastrointestinal pain—Procarbazine—brain cancer	0.00308	0.00338	CcSEcCtD
Metolazone—Erythema multiforme—Temozolomide—brain cancer	0.00303	0.00333	CcSEcCtD
Metolazone—Discomfort—Hydroxyurea—brain cancer	0.00301	0.0033	CcSEcCtD
Metolazone—Urticaria—Procarbazine—brain cancer	0.00299	0.00329	CcSEcCtD
Metolazone—Tinnitus—Temozolomide—brain cancer	0.00299	0.00328	CcSEcCtD
Metolazone—Abdominal pain—Procarbazine—brain cancer	0.00298	0.00327	CcSEcCtD
Metolazone—CA12—endocrine gland—brain cancer	0.00288	0.0323	CbGeAlD
Metolazone—Chills—Temozolomide—brain cancer	0.00288	0.00316	CcSEcCtD
Metolazone—Thrombocytopenia—Hydroxyurea—brain cancer	0.00286	0.00313	CcSEcCtD
Metolazone—CA12—head—brain cancer	0.00284	0.0319	CbGeAlD
Metolazone—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00283	0.00311	CcSEcCtD
Metolazone—CA4—telencephalon—brain cancer	0.00283	0.0317	CbGeAlD
Metolazone—Neuropathy peripheral—Etoposide—brain cancer	0.0028	0.00308	CcSEcCtD
Metolazone—Back pain—Carmustine—brain cancer	0.00279	0.00307	CcSEcCtD
Metolazone—Anorexia—Hydroxyurea—brain cancer	0.00278	0.00305	CcSEcCtD
Metolazone—Hypersensitivity—Procarbazine—brain cancer	0.00278	0.00305	CcSEcCtD
Metolazone—Dysgeusia—Temozolomide—brain cancer	0.00273	0.003	CcSEcCtD
Metolazone—Vision blurred—Carmustine—brain cancer	0.00272	0.00299	CcSEcCtD
Metolazone—Asthenia—Procarbazine—brain cancer	0.0027	0.00297	CcSEcCtD
Metolazone—Back pain—Temozolomide—brain cancer	0.0027	0.00296	CcSEcCtD
Metolazone—Anaemia—Carmustine—brain cancer	0.00267	0.00293	CcSEcCtD
Metolazone—Agranulocytosis—Etoposide—brain cancer	0.00267	0.00293	CcSEcCtD
Metolazone—Pruritus—Procarbazine—brain cancer	0.00267	0.00293	CcSEcCtD
Metolazone—Agitation—Carmustine—brain cancer	0.00265	0.00291	CcSEcCtD
Metolazone—Vision blurred—Temozolomide—brain cancer	0.00263	0.00289	CcSEcCtD
Metolazone—CA12—central nervous system—brain cancer	0.00259	0.0291	CbGeAlD
Metolazone—Somnolence—Hydroxyurea—brain cancer	0.00259	0.00285	CcSEcCtD
Metolazone—Ill-defined disorder—Temozolomide—brain cancer	0.00259	0.00284	CcSEcCtD
Metolazone—Leukopenia—Carmustine—brain cancer	0.00259	0.00284	CcSEcCtD
Metolazone—CA5B—endocrine gland—brain cancer	0.00258	0.029	CbGeAlD
Metolazone—Anaemia—Temozolomide—brain cancer	0.00258	0.00283	CcSEcCtD
Metolazone—Diarrhoea—Procarbazine—brain cancer	0.00258	0.00283	CcSEcCtD
Metolazone—Dyspepsia—Hydroxyurea—brain cancer	0.00257	0.00282	CcSEcCtD
Metolazone—Agitation—Temozolomide—brain cancer	0.00257	0.00282	CcSEcCtD
Metolazone—CA5B—head—brain cancer	0.00255	0.0286	CbGeAlD
Metolazone—Decreased appetite—Hydroxyurea—brain cancer	0.00253	0.00278	CcSEcCtD
Metolazone—Malaise—Temozolomide—brain cancer	0.00252	0.00276	CcSEcCtD
Metolazone—Fatigue—Hydroxyurea—brain cancer	0.00251	0.00276	CcSEcCtD
Metolazone—Vertigo—Temozolomide—brain cancer	0.00251	0.00275	CcSEcCtD
Metolazone—Leukopenia—Temozolomide—brain cancer	0.0025	0.00274	CcSEcCtD
Metolazone—Hypertension—Carmustine—brain cancer	0.00249	0.00274	CcSEcCtD
Metolazone—Constipation—Hydroxyurea—brain cancer	0.00249	0.00274	CcSEcCtD
Metolazone—Pain—Hydroxyurea—brain cancer	0.00249	0.00274	CcSEcCtD
Metolazone—Dizziness—Procarbazine—brain cancer	0.00249	0.00274	CcSEcCtD
Metolazone—Palpitations—Temozolomide—brain cancer	0.00247	0.00271	CcSEcCtD
Metolazone—Chest pain—Carmustine—brain cancer	0.00246	0.0027	CcSEcCtD
Metolazone—Anxiety—Carmustine—brain cancer	0.00245	0.00269	CcSEcCtD
Metolazone—Cough—Temozolomide—brain cancer	0.00244	0.00267	CcSEcCtD
Metolazone—Erythema multiforme—Etoposide—brain cancer	0.00243	0.00266	CcSEcCtD
Metolazone—Hypertension—Temozolomide—brain cancer	0.00241	0.00265	CcSEcCtD
Metolazone—Feeling abnormal—Hydroxyurea—brain cancer	0.0024	0.00264	CcSEcCtD
Metolazone—Vomiting—Procarbazine—brain cancer	0.0024	0.00263	CcSEcCtD
Metolazone—Arthralgia—Temozolomide—brain cancer	0.00238	0.00261	CcSEcCtD
Metolazone—Rash—Procarbazine—brain cancer	0.00238	0.00261	CcSEcCtD
Metolazone—Dermatitis—Procarbazine—brain cancer	0.00237	0.00261	CcSEcCtD
Metolazone—Anxiety—Temozolomide—brain cancer	0.00237	0.0026	CcSEcCtD
Metolazone—Headache—Procarbazine—brain cancer	0.00236	0.00259	CcSEcCtD
Metolazone—Discomfort—Temozolomide—brain cancer	0.00235	0.00258	CcSEcCtD
Metolazone—CA5B—central nervous system—brain cancer	0.00233	0.0261	CbGeAlD
Metolazone—Dry mouth—Temozolomide—brain cancer	0.00232	0.00255	CcSEcCtD
Metolazone—Thrombocytopenia—Carmustine—brain cancer	0.00231	0.00253	CcSEcCtD
Metolazone—Chills—Etoposide—brain cancer	0.0023	0.00253	CcSEcCtD
Metolazone—CA4—pituitary gland—brain cancer	0.0023	0.0258	CbGeAlD
Metolazone—Anorexia—Carmustine—brain cancer	0.00225	0.00247	CcSEcCtD
Metolazone—Nausea—Procarbazine—brain cancer	0.00224	0.00246	CcSEcCtD
Metolazone—Thrombocytopenia—Temozolomide—brain cancer	0.00223	0.00245	CcSEcCtD
Metolazone—CA4—medulla oblongata—brain cancer	0.00222	0.0249	CbGeAlD
Metolazone—Dysgeusia—Etoposide—brain cancer	0.00219	0.0024	CcSEcCtD
Metolazone—Anorexia—Temozolomide—brain cancer	0.00217	0.00238	CcSEcCtD
Metolazone—Back pain—Etoposide—brain cancer	0.00216	0.00237	CcSEcCtD
Metolazone—Hypersensitivity—Hydroxyurea—brain cancer	0.00215	0.00236	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00215	0.00236	CcSEcCtD
Metolazone—Muscle spasms—Etoposide—brain cancer	0.00215	0.00236	CcSEcCtD
Metolazone—Insomnia—Carmustine—brain cancer	0.00213	0.00234	CcSEcCtD
Metolazone—Paraesthesia—Carmustine—brain cancer	0.00212	0.00232	CcSEcCtD
Metolazone—Somnolence—Carmustine—brain cancer	0.0021	0.0023	CcSEcCtD
Metolazone—Asthenia—Hydroxyurea—brain cancer	0.00209	0.0023	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00208	0.00228	CcSEcCtD
Metolazone—Ill-defined disorder—Etoposide—brain cancer	0.00207	0.00228	CcSEcCtD
Metolazone—Anaemia—Etoposide—brain cancer	0.00206	0.00227	CcSEcCtD
Metolazone—Insomnia—Temozolomide—brain cancer	0.00206	0.00226	CcSEcCtD
Metolazone—CA12—brain—brain cancer	0.00206	0.0231	CbGeAlD
Metolazone—Decreased appetite—Carmustine—brain cancer	0.00205	0.00225	CcSEcCtD
Metolazone—Paraesthesia—Temozolomide—brain cancer	0.00205	0.00225	CcSEcCtD
Metolazone—CA4—midbrain—brain cancer	0.00203	0.0228	CbGeAlD
Metolazone—Somnolence—Temozolomide—brain cancer	0.00203	0.00222	CcSEcCtD
Metolazone—Pain—Carmustine—brain cancer	0.00202	0.00221	CcSEcCtD
Metolazone—Constipation—Carmustine—brain cancer	0.00202	0.00221	CcSEcCtD
Metolazone—Malaise—Etoposide—brain cancer	0.00201	0.00221	CcSEcCtD
Metolazone—Vertigo—Etoposide—brain cancer	0.00201	0.0022	CcSEcCtD
Metolazone—Dyspepsia—Temozolomide—brain cancer	0.00201	0.0022	CcSEcCtD
Metolazone—Leukopenia—Etoposide—brain cancer	0.002	0.00219	CcSEcCtD
Metolazone—Diarrhoea—Hydroxyurea—brain cancer	0.002	0.00219	CcSEcCtD
Metolazone—Decreased appetite—Temozolomide—brain cancer	0.00198	0.00217	CcSEcCtD
Metolazone—CA4—spinal cord—brain cancer	0.00198	0.0222	CbGeAlD
Metolazone—Fatigue—Temozolomide—brain cancer	0.00196	0.00216	CcSEcCtD
Metolazone—Loss of consciousness—Etoposide—brain cancer	0.00196	0.00216	CcSEcCtD
Metolazone—Cough—Etoposide—brain cancer	0.00195	0.00214	CcSEcCtD
Metolazone—Constipation—Temozolomide—brain cancer	0.00195	0.00214	CcSEcCtD
Metolazone—Pain—Temozolomide—brain cancer	0.00195	0.00214	CcSEcCtD
Metolazone—Feeling abnormal—Carmustine—brain cancer	0.00194	0.00213	CcSEcCtD
Metolazone—Hypertension—Etoposide—brain cancer	0.00193	0.00212	CcSEcCtD
Metolazone—Dizziness—Hydroxyurea—brain cancer	0.00193	0.00212	CcSEcCtD
Metolazone—Gastrointestinal pain—Carmustine—brain cancer	0.00193	0.00212	CcSEcCtD
Metolazone—Chest pain—Etoposide—brain cancer	0.0019	0.00209	CcSEcCtD
Metolazone—Discomfort—Etoposide—brain cancer	0.00188	0.00206	CcSEcCtD
Metolazone—Feeling abnormal—Temozolomide—brain cancer	0.00188	0.00206	CcSEcCtD
Metolazone—Abdominal pain—Carmustine—brain cancer	0.00186	0.00205	CcSEcCtD
Metolazone—Gastrointestinal pain—Temozolomide—brain cancer	0.00186	0.00205	CcSEcCtD
Metolazone—Vomiting—Hydroxyurea—brain cancer	0.00185	0.00204	CcSEcCtD
Metolazone—CA5B—brain—brain cancer	0.00185	0.0207	CbGeAlD
Metolazone—Rash—Hydroxyurea—brain cancer	0.00184	0.00202	CcSEcCtD
Metolazone—Dermatitis—Hydroxyurea—brain cancer	0.00184	0.00202	CcSEcCtD
Metolazone—Headache—Hydroxyurea—brain cancer	0.00183	0.00201	CcSEcCtD
Metolazone—Urticaria—Temozolomide—brain cancer	0.00181	0.00199	CcSEcCtD
Metolazone—Abdominal pain—Temozolomide—brain cancer	0.0018	0.00198	CcSEcCtD
Metolazone—Thrombocytopenia—Etoposide—brain cancer	0.00178	0.00196	CcSEcCtD
Metolazone—CA4—endocrine gland—brain cancer	0.00178	0.02	CbGeAlD
Metolazone—CA4—head—brain cancer	0.00176	0.0197	CbGeAlD
Metolazone—Anorexia—Etoposide—brain cancer	0.00174	0.00191	CcSEcCtD
Metolazone—Hypersensitivity—Carmustine—brain cancer	0.00174	0.00191	CcSEcCtD
Metolazone—Nausea—Hydroxyurea—brain cancer	0.00173	0.0019	CcSEcCtD
Metolazone—Asthenia—Carmustine—brain cancer	0.00169	0.00186	CcSEcCtD
Metolazone—Hypersensitivity—Temozolomide—brain cancer	0.00168	0.00184	CcSEcCtD
Metolazone—Paraesthesia—Etoposide—brain cancer	0.00164	0.0018	CcSEcCtD
Metolazone—Asthenia—Temozolomide—brain cancer	0.00163	0.00179	CcSEcCtD
Metolazone—Somnolence—Etoposide—brain cancer	0.00162	0.00178	CcSEcCtD
Metolazone—Diarrhoea—Carmustine—brain cancer	0.00161	0.00177	CcSEcCtD
Metolazone—Pruritus—Temozolomide—brain cancer	0.00161	0.00177	CcSEcCtD
Metolazone—CA4—central nervous system—brain cancer	0.00161	0.018	CbGeAlD
Metolazone—Decreased appetite—Etoposide—brain cancer	0.00158	0.00174	CcSEcCtD
Metolazone—Fatigue—Etoposide—brain cancer	0.00157	0.00173	CcSEcCtD
Metolazone—CA4—cerebellum—brain cancer	0.00157	0.0176	CbGeAlD
Metolazone—Dizziness—Carmustine—brain cancer	0.00156	0.00171	CcSEcCtD
Metolazone—Pain—Etoposide—brain cancer	0.00156	0.00171	CcSEcCtD
Metolazone—Constipation—Etoposide—brain cancer	0.00156	0.00171	CcSEcCtD
Metolazone—Diarrhoea—Temozolomide—brain cancer	0.00156	0.00171	CcSEcCtD
Metolazone—Dizziness—Temozolomide—brain cancer	0.00151	0.00165	CcSEcCtD
Metolazone—Feeling abnormal—Etoposide—brain cancer	0.0015	0.00165	CcSEcCtD
Metolazone—Vomiting—Carmustine—brain cancer	0.0015	0.00165	CcSEcCtD
Metolazone—Gastrointestinal pain—Etoposide—brain cancer	0.00149	0.00164	CcSEcCtD
Metolazone—Rash—Carmustine—brain cancer	0.00149	0.00163	CcSEcCtD
Metolazone—Dermatitis—Carmustine—brain cancer	0.00148	0.00163	CcSEcCtD
Metolazone—Headache—Carmustine—brain cancer	0.00148	0.00162	CcSEcCtD
Metolazone—Vomiting—Temozolomide—brain cancer	0.00145	0.00159	CcSEcCtD
Metolazone—Urticaria—Etoposide—brain cancer	0.00145	0.00159	CcSEcCtD
Metolazone—Abdominal pain—Etoposide—brain cancer	0.00144	0.00158	CcSEcCtD
Metolazone—Rash—Temozolomide—brain cancer	0.00144	0.00158	CcSEcCtD
Metolazone—Dermatitis—Temozolomide—brain cancer	0.00144	0.00158	CcSEcCtD
Metolazone—Headache—Temozolomide—brain cancer	0.00143	0.00157	CcSEcCtD
Metolazone—Nausea—Carmustine—brain cancer	0.0014	0.00154	CcSEcCtD
Metolazone—Nausea—Temozolomide—brain cancer	0.00135	0.00149	CcSEcCtD
Metolazone—Hypersensitivity—Etoposide—brain cancer	0.00134	0.00147	CcSEcCtD
Metolazone—Asthenia—Etoposide—brain cancer	0.00131	0.00144	CcSEcCtD
Metolazone—Pruritus—Etoposide—brain cancer	0.00129	0.00142	CcSEcCtD
Metolazone—CA4—brain—brain cancer	0.00127	0.0143	CbGeAlD
Metolazone—Diarrhoea—Etoposide—brain cancer	0.00125	0.00137	CcSEcCtD
Metolazone—Dizziness—Etoposide—brain cancer	0.00121	0.00132	CcSEcCtD
Metolazone—Vomiting—Etoposide—brain cancer	0.00116	0.00127	CcSEcCtD
Metolazone—Rash—Etoposide—brain cancer	0.00115	0.00126	CcSEcCtD
Metolazone—Dermatitis—Etoposide—brain cancer	0.00115	0.00126	CcSEcCtD
Metolazone—Headache—Etoposide—brain cancer	0.00114	0.00125	CcSEcCtD
Metolazone—Nausea—Etoposide—brain cancer	0.00108	0.00119	CcSEcCtD
